Contract Notice Detail

Summary Information

Summary Information
 
31/4371/2023 
Medicamento Nistatina (susp.oral) [100.000 UI/ ML; FRS] 
Tendering Phase
Awarded
31/4371/2023 - Medicamento Nistatina (susp.oral) [100.000 UI/ ML; FRS] 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
N66 - NISTATINA (susp. oral) [100.000 UI/ ML; FRS]2 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua Leão Penedo 8000-338 União das freguesias de Faro (Sé e São Pedro) Faro PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
10/17/2023 11:45 AM (UTC +1 hour)
 
3/22/2021 12:00 AM (UTC 0 hours)
 
10/18/2023 5:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
31000043712023.xlsx31000043712023.xlsxDownload
convite 258º.pdfconvite 258º.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
 
 
 1 
Questionário
 1.1  
 Lote 1Section for Lot - N66 - NISTATINA (susp. oral) [100.000 UI/ ML; FRS]
 1.1.1   
Lote 1
Bill of Quantities *
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
     
Preço Total
0,00
EUR
     
 
Cód. ArtigoReferência InternaDescriçãoQtUnidadePreço UnitárioPreço Total
     
N66
NISTATINA (susp. oral) [100.000 UI/ ML; FRS]
200,00
UN
 
503934640 | Alloga Logifarma, S.A. | CPA:2021041/354/0047 | NºAIM:8344705;
  

Evaluation

Evaluation

Evaluation General Settings

Evaluation General Settings
MostEconomicallyAdvantageousTender 
Manual 

Evaluation Items

Evaluation Items
NameLot
Regras de avaliação para o lote 11 - N66 - NISTATINA (susp. oral) [100.000 UI/ ML; FRS]
 

Critérios de Adjudicação



  Peso (%)**
 1 Preço100
 
 
 

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...